Emerging immunotherapies and targeted therapies take aim at recently identified biomarkers ...

Immunotherapy, targeted treatments, HIPEC, and new delivery options ...

The specifics of endoscopic/surgical resection and perioperative treatment ...

Scotland has approved its first CLDN18.2-targeted therapy for advanced gastric and GEJ cancer, expanding options for patients ...

Akeso has now been advised to submit a sNDA to Chinese regulators for cadonilimab’s approval in gastric cancer by an ...

Japanese pharmaceutical company Daiichi Sankyo announced on Tuesday that Daiichi Sankyo and AstraZeneca's ENHERTU® has been granted conditional approval in China for the treatment of certain patients ...

In attempt to assess treatment patterns in advanced gastric cancer across racial and ethnic groups throughout the U.S., ...

Clinicians can help reduce gastric cancer incidence and mortality in high-risk groups through endoscopic screening and surveillance of precancerous conditions, such as gastric intestinal metaplasia ...

Nutritional support enhances treatment continuity in malnourished patients with advanced gastric cancer and independently ...

Proton pump inhibitors are among the most commonly prescribed medications worldwide, but concerns about a possible link to ...

While heartburn medication can be a lifesaver for those suffering from gastric reflux, several studies over the years have ...